Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

This study has been terminated.
(DSMB recommendation for slow enrollment)
Sponsor:
Information provided by (Responsible Party):
Ivor Douglas, Denver Health and Hospital Authority
ClinicalTrials.gov Identifier:
NCT01362205
First received: May 24, 2010
Last updated: February 6, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)